Y-mAbs Therapeutics, Inc. Human Resources Contracts & Agreements
22 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Compensation Agreements (2)
- Employment Agreements (8)
- Separation Agreements (2)
- Severance Agreements (1)
- Separation Agreement, entered into on July 16, 2024, between Bo Kruse and Y-mAbs Therapeutics A/S (Filed With SEC on July 19, 2024)
- Employment Agreement, entered into on June 28, 2024, between Peter Pfreundschuh and the Company (Filed With SEC on July 1, 2024)
- Amended and Restated Non-Employee Director Compensation Policy, effective April 26, 2024 (Filed With SEC on May 7, 2024)
- Severance Agreement dated March 21, 2024 between Y-mAbs Therapeutics A/S and Steen Lisby (Filed With SEC on May 7, 2024)
- Form of Performance Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2018 Equity Incentive Plan (Filed With SEC on February 29, 2024)
- Amendment to Employment Agreement for Dr. Vignesh Rajah, effective as of January 1, 2024 (Filed With SEC on February 29, 2024)
- Employment Agreement, entered into on October 17, 2023, between Michael Rossi and the Company (Filed With SEC on October 18, 2023)
- Employment Agreement for Ms. Susan Smith, effective as of January 1, 2022 (Filed With SEC on March 30, 2023)
- Non-Employee Director Compensation Policy, adopted on January 17, 2023 (Filed With SEC on March 30, 2023)
- Separation Agreement and General Release, effective as of September 22, 2022, between Y-mAbs Therapeutics, Inc. and Claus Juan Mller San Pedro (Filed With SEC on November 7, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement for directors under the 2018 Equity Incentive Plan (Filed With SEC on November 7, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on November 7, 2022)
- Form of Retention Bonus Agreement of Y-mAbs Therapeutics, Inc (Filed With SEC on August 8, 2022)
- Form of Retention Bonus Agreement of Y-mAbs Therapeutics A/S (Filed With SEC on August 8, 2022)
- Retention Bonus Agreement, dated May 30, 2022 by and between EVP and Chief Financial Officer, Bo Kruse and Y-mAbs Therapeutics A/S (Filed With SEC on August 8, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on August 8, 2022)
- Amendment to Employment Agreement for Dr. Vignesh Rajah, effective as of March 10, 2021 (Filed With SEC on May 9, 2022)
- Employment Agreement for Dr. Vignesh Rajah, effective as of June 2, 2020 (Filed With SEC on May 9, 2022)
- Amendment to Employment Agreement for Dr. Steen Lisby, effective as of June 1, 2020 (Filed With SEC on May 9, 2022)
- Employment Agreement for Dr. Steen Lisby, effective as of August 1, 2017 (Filed With SEC on May 9, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (as amended, directors) (Filed With SEC on November 5, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2018 Equity Incentive Plan (as amended, employees, consultants and service providers other than directors) (Filed With SEC on November 5, 2020)
